Pfizer Inc. v. United States of America
Case Number:
17-2307
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
February 14, 2018
Pfizer Fights In 2nd Circ. Over Interest Claims Deadline
Pfizer Inc. faced off against the U.S. government in the Second Circuit on Tuesday in a bid to extract $8.3 million of interest on a delayed tax refund, telling judges it did not miss the deadline for attempting to collect the payment.
-
December 01, 2017
Pfizer Tells 2nd Circ. Feds Lack Immunity In $8.3M Tax Row
Pharmaceutical giant Pfizer Inc. argued to the Second Circuit Wednesday that it had satisfied waivers of sovereign immunity against the federal government in a dispute centered on the company's claim for $8.3 million in interest it alleges is owed on taxes it overpaid.
-
November 16, 2017
Gov't Asks 2nd Circ. To Toss Pfizer's $8.3M Interest Case
The U.S. on Wednesday slammed Pfizer's appeal to the Second Circuit of a district court order dismissing its $8.3 million interest suit, saying the pharmaceutical giant brought its action in the wrong court and after the proper statute of limitations period had passed.
-
October 13, 2017
Pfizer Takes $8.3M Interest Case Against US To 2nd Circ.
Pharmaceutical giant Pfizer Inc. asked the Second Circuit on Thursday to reverse a district court ruling dismissing its claim seeking $8.3 million in overpayment interest, saying the court erred in applying the two-year statute of limitations that applies to tax refund claims.